Using metabolomics to assess myocardial metabolism and energetics in heart failure
- 1 February 2013
- journal article
- review article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 55, 12-18
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13 C magnetic resonanceProceedings of the National Academy of Sciences, 2011
- Could 13C MRI assist clinical decision‐making for patients with heart disease?NMR in Biomedicine, 2011
- Metabolite profiles and the risk of developing diabetesNature Medicine, 2011
- Delineation of substrate selection and anaplerosis in tricarboxylic acid cycle of the heart by 13C NMR spectroscopy and mass spectrometryNMR in Biomedicine, 2010
- Assessment of Metabolic Phenotypes in Patients with Non-ischemic Dilated Cardiomyopathy Undergoing Cardiac Resynchronization TherapyJournal of Cardiovascular Translational Research, 2010
- Hospitalizations After Heart Failure DiagnosisJACC, 2009
- Inhibition of carbohydrate oxidation during the first minute of reperfusion after brief ischemia: NMR detection of hyperpolarized 13CO2 and H13COMagnetic Resonance in Medicine, 2008
- HMDB: a knowledgebase for the human metabolomeNucleic Acids Research, 2008
- Disorders of carnitine transport and the carnitine cycleAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2006
- Trends in Heart Failure Incidence and Survival in a Community-Based PopulationJAMA, 2004